Monday Feb 28, 2022
Season 1, Episode 4 (Safety & Side Effects of Hair Loss Treatments: Spironolactone, Tofacitinib, Doxycycline, Minoxidil, Methotrexate, Laser Hair Removal)
STUDIES HIGHLIGHTED IN THIS EPISODE
Korbi M et al (starts at 1:58). Topical minoxidil-induced paresthesia. Dermatol Ther. 2022 Jan 20;e15328.
Panigrahi M et al (starts at 9:37). A recent surge of doxycycline-induced pill esophagitis during the corona virus disease 2019 (COVID-19) pandemic. Indian J Gastroenterol Jan 2022
Panigrahi M et al (starts at 14:45). A recent surge of doxycycline-induced pill esophagitis during the corona virus disease 2019 (COVID-19) pandemic. Indian J Gastroenterol Jan 2022
Bommareddy et al (starts at 18:48). Association of Spironolactone Use With Risk of Cancer: A Systematic Review and Meta-analysis. JAMA Dermatol 2022 Feb 9
Ytterberg SR et al (starts at 25:13). Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med. 2022 Jan 27;386(4):316-326. doi:
Snast I et al (starts at 37:45). Paradoxical Hypertrichosis Associated with Laser and Light Therapy for Hair Removal: A Systematic Review and Meta-analysis Am J Clin Dermatol 2021 Sep;22(5):615-624
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.